» Articles » PMID: 35528247

A Review on the Recent Advances and Application of Vaccines Against Fish Pathogens in Aquaculture

Overview
Journal Aquac Int
Date 2022 May 9
PMID 35528247
Authors
Affiliations
Soon will be listed here.
Abstract

Globally, aquaculture has faced serious economic problems due to bacterial, viral, and various other infectious diseases of different origins. Even though such diseases are being detected and simultaneously treated with several therapeutic and prophylactic methods, the broad-spectrum activity of vaccines plays a vital role as a preventive measure in aquaculture. However, treatments like use of antibiotics and probiotics seem to be less effective when new mutant strains develop and disease causing pathogens become resistant to commonly used antibiotics. Therefore, vaccines developed by using recent advanced molecular techniques can be considered as an effective way of treating disease causing pathogens in aquatic organisms. The present review emphasizes on the current advances in technology and future outlook with reference to different types of vaccines used in the aquaculture industries. Beginning with traditional killed/inactivated and live attenuated vaccines, this work culminates in the review of modern new generation ones including recombinant, synthetic peptides, mucosal and DNA, subunit, nanoparticle-based and plant-based edible vaccines, reverse vaccinology, and monovalent and polyvalent vaccines.

Citing Articles

Advances and Challenges in Vaccine Development: Immunological Insights and Future Perspectives.

Miryala K, Swain B Vaccines (Basel). 2025; 13(2).

PMID: 40006748 PMC: 11861604. DOI: 10.3390/vaccines13020202.


Improved Protective Efficacy in Rainbow Trout (Oncorhynchus mykiss) Against Vibrio anguillarum Through Immunization with a Combination of Formalin-Killed and Auxotrophic-Live V. anguillarum.

Lee K, Kim K Mar Biotechnol (NY). 2025; 27(1):35.

PMID: 39869218 DOI: 10.1007/s10126-025-10414-3.


Advances in Vaccine Adjuvants for Teleost Fish: Implications for Aquatic Welfare and the Potential of Nanoparticle-Based Formulations.

Tammas I, Bitchava K, Gelasakis A Vaccines (Basel). 2025; 12(12.

PMID: 39772009 PMC: 11679523. DOI: 10.3390/vaccines12121347.


Fish Brain Cell Lines Can Be Infected with Adenoviral Vectors and Support Transgene Expression-An In Vitro Approach.

Cuesta A, Valero Y Int J Mol Sci. 2025; 25(24.

PMID: 39769121 PMC: 11676386. DOI: 10.3390/ijms252413357.


Navigating Fish Immunity: Focus on Mucosal Immunity and the Evolving Landscape of Mucosal Vaccines.

Hopo M, Mabrok M, Abu-Elala N, Yu Y Biology (Basel). 2025; 13(12.

PMID: 39765647 PMC: 11727089. DOI: 10.3390/biology13120980.


References
1.
Ji J, Torrealba D, Ruyra A, Roher N . Nanodelivery Systems as New Tools for Immunostimulant or Vaccine Administration: Targeting the Fish Immune System. Biology (Basel). 2015; 4(4):664-96. PMC: 4690013. DOI: 10.3390/biology4040664. View

2.
Purcell M, Nichols K, Winton J, Kurath G, Thorgaard G, Wheeler P . Comprehensive gene expression profiling following DNA vaccination of rainbow trout against infectious hematopoietic necrosis virus. Mol Immunol. 2006; 43(13):2089-106. DOI: 10.1016/j.molimm.2005.12.005. View

3.
Ashraf U, Lu Y, Lin L, Yuan J, Wang M, Liu X . Spring viraemia of carp virus: recent advances. J Gen Virol. 2016; 97(5):1037-1051. DOI: 10.1099/jgv.0.000436. View

4.
Donnelly J, Ulmer J, Liu M . DNA vaccines. Life Sci. 1997; 60(3):163-72. DOI: 10.1016/s0024-3205(96)00502-4. View

5.
Di Pasquale A, Preiss S, Da Silva F, Garcon N . Vaccine Adjuvants: from 1920 to 2015 and Beyond. Vaccines (Basel). 2015; 3(2):320-43. PMC: 4494348. DOI: 10.3390/vaccines3020320. View